Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NTN BuzztimeXTL BiopharmaceuticalsBioxytranSonoma PharmaceuticalsEledon Pharmaceuticals
SymbolNYSEAMERICAN:NTNNASDAQ:XTLBOTCMKTS:BIXTNASDAQ:SNOANASDAQ:ELDN
Price Information
Current Price$6.43$3.28$0.18$8.10$10.58
52 Week RangeN/AN/AN/AN/ABuy
MarketRank™
Overall Score0.40.60.00.51.6
Analysis Score0.00.00.00.03.5
Community Score2.02.80.02.53.8
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.00.6
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/ABuy
Consensus Price TargetN/AN/AN/AN/A$29.50
% Upside from Price TargetN/AN/AN/AN/A178.83% upside
Trade Information
Market Cap$19.14 million$16.86 million$18.12 million$16.82 million$15.19 million
Beta0.720.83-6.810.771.92
Average Volume1,629,816262,3664,722288,32572,897
Sales & Book Value
Annual Revenue$19.81 millionN/AN/A$18.94 millionN/A
Price / Sales0.97N/AN/A0.89N/A
Cashflow$1.47 per shareN/AN/AN/AN/A
Price / Cash4.38N/AN/AN/AN/A
Book Value$1.76 per share$1.36 per share($0.01) per share$4.90 per share$13.13 per share
Price / Book3.65N/AN/A1.65N/A
Profitability
Net Income$-2,050,000.00$-1,350,000.00$-1,860,000.00$-2,950,000.00$-16,010,000.00
EPSN/AN/AN/AN/A($21.58)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-61.42%N/AN/A-6.04%N/A
Return on Equity (ROE)-162.54%-38.54%N/A-29.78%-133.49%
Return on Assets (ROA)-49.94%-37.40%-3,472.56%-18.65%-30.52%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio3.30%N/AN/A0.11%N/A
Current Ratio0.95%33.03%N/A3.56%18.78%
Quick Ratio0.95%28.23%N/A2.75%18.78%
Ownership Information
Institutional Ownership Percentage6.31%8.55%N/A9.02%N/A
Insider Ownership Percentage24.20%N/AN/A5.60%2.20%
Miscellaneous
Employees19N/A2197
Shares Outstanding2.98 million5.14 million100.65 million2.08 million1.44 million
Next Earnings Date5/18/2021 (Estimated)5/26/2021 (Estimated)5/12/2021 (Estimated)7/9/2021 (Estimated)5/21/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Eledon Pharmaceuticals Inc (ELDN)Eledon Pharmaceuticals Inc (ELDN)
investing.com - April 12 at 12:54 AM
Eledon Pharmaceuticals, Inc. (ELDN)Eledon Pharmaceuticals, Inc. (ELDN)
realmoney.thestreet.com - April 12 at 12:54 AM
Research Analysts Issue Forecasts for Eledon Pharmaceuticals, Inc.s Q1 2021 Earnings (NASDAQ:ELDN)Research Analysts Issue Forecasts for Eledon Pharmaceuticals, Inc.'s Q1 2021 Earnings (NASDAQ:ELDN)
americanbankingnews.com - April 2 at 7:58 AM
Eledon Pharmaceuticals IncEledon Pharmaceuticals Inc
reuters.com - March 30 at 7:10 PM
Eledon Pharmaceuticals, Inc. to Host Earnings CallEledon Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - March 30 at 7:10 PM
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial ResultsEledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial Results
finance.yahoo.com - March 30 at 7:10 PM
Eledon Pharmaceuticals (NASDAQ:ELDN) vs. Dr. Reddys Laboratories (NYSE:RDY) Head to Head ComparisonEledon Pharmaceuticals (NASDAQ:ELDN) vs. Dr. Reddy's Laboratories (NYSE:RDY) Head to Head Comparison
americanbankingnews.com - March 29 at 8:38 PM
-$0.42 EPS Expected for Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) This Quarter-$0.42 EPS Expected for Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) This Quarter
americanbankingnews.com - March 29 at 2:26 PM
Eledon Pharmaceuticals (NASDAQ:ELDN) Rating Reiterated by SVB LeerinkEledon Pharmaceuticals (NASDAQ:ELDN) Rating Reiterated by SVB Leerink
americanbankingnews.com - March 29 at 12:18 PM
Eledon Pharmaceuticals (NASDAQ:ELDN) Receives New Coverage from Analysts at Cantor FitzgeraldEledon Pharmaceuticals (NASDAQ:ELDN) Receives New Coverage from Analysts at Cantor Fitzgerald
americanbankingnews.com - March 29 at 10:02 AM
What Kind Of Shareholders Own Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)?What Kind Of Shareholders Own Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)?
finance.yahoo.com - March 29 at 8:06 AM
Eledon Pharmaceuticals, Inc. Expected to Post FY2021 Earnings of ($1.16) Per Share (NASDAQ:ELDN)Eledon Pharmaceuticals, Inc. Expected to Post FY2021 Earnings of ($1.16) Per Share (NASDAQ:ELDN)
americanbankingnews.com - March 25 at 8:14 AM
Eledon Pharmaceuticals (ELDN) Scheduled to Post Quarterly Earnings on TuesdayEledon Pharmaceuticals (ELDN) Scheduled to Post Quarterly Earnings on Tuesday
americanbankingnews.com - March 24 at 9:05 AM
Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday,Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday,
apnews.com - March 23 at 9:25 AM
Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday, March 30Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday, March 30
finance.yahoo.com - March 23 at 9:25 AM
Eledon Pharmaceuticals (NASDAQ:ELDN) Given Outperform Rating at Lifesci CapitalEledon Pharmaceuticals (NASDAQ:ELDN) Given Outperform Rating at Lifesci Capital
americanbankingnews.com - March 23 at 6:48 AM
Eledon Pharmaceuticals (NASDAQ:ELDN) Research Coverage Started at Cantor FitzgeraldEledon Pharmaceuticals (NASDAQ:ELDN) Research Coverage Started at Cantor Fitzgerald
americanbankingnews.com - March 22 at 8:56 PM
Eledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer HiresEledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer Hires
finance.yahoo.com - March 15 at 8:36 AM
Eledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference Nasdaq:ELDNEledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference Nasdaq:ELDN
compsmag.com - March 2 at 2:16 PM
Eledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences ConferenceEledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 9:09 AM
Eledon Pharmaceuticals to Present at 10th Annual SVB Leerink Global Healthcare ConferenceEledon Pharmaceuticals to Present at 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 17 at 12:00 PM
DateCompanyBrokerageAction
11/9/2018Sonoma PharmaceuticalsMaxim GroupReiterated Rating
7/20/2018Sonoma PharmaceuticalsBenchmarkReiterated Rating
3/29/2021Eledon PharmaceuticalsSVB LeerinkReiterated Rating
3/29/2021Eledon PharmaceuticalsCantor FitzgeraldInitiated Coverage
3/18/2021Eledon PharmaceuticalsLifesci CapitalReiterated Rating
(Data available from 4/13/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.